Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units
NCT01656603Phase 2Recruiting
- Sponsor
- New York Blood Center
- Start
- Feb 2012
- Primary completion
- Dec 2030
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of cord blood unit in hematopoietic system disorder, sponsored by New York Blood Center. Started Feb 2012; status: recruiting.
02
Drugs
cord blood unit
03
Conditions
hematopoietic system disorder
Beyond the preview
Go deeper on NCT01656603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656603.